Tang Xiaolong, Zhang Jianwei, Che Xu, Lan Zhongmin, Chen Yingtai, Wang Chengfeng
Department of Abdominal Surgery, Cancer Institute & Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, No. 17, South of Pan Jiayuan Street, Chaoyang District, Beijing, China.
J Gastrointest Surg. 2016 Apr;20(4):693-9. doi: 10.1007/s11605-015-3064-0. Epub 2016 Jan 5.
Mucinous gastric carcinoma (MGC) is a rare kind of malignancy with unclear prognosis. This study aims to assess the clinicopathological features and prognosis of MGC.
We retrospectively analyzed a consecutive series of 244 MGC patients who underwent radical gastrectomy with D2 lymphadenectomy, and compared the data with 260 gastric signet ring cell carcinoma (SRC) patients.
The univariate survival analysis showed that the surgical types, diameter of the primary tumor, the Borrmann type, pathological depth of tumor invasion (pT), pathological number of metastatic lymph node (pN), pathological tumor lymph metastasis (pTNM), and vascular invasion were all significant predictors of survival (all P < 0.05). The multivariate survival analysis revealed that the diameter of the tumor, the Borrmann type, pT, pTNM stage, and vascular invasion as an independent predictive factor of survival (all P < 0.05). Compared with the SRC group, the MGC group had more male patients, more elder patients, larger tumor diameter, more T3 and T4 invasion to the gastric wall, more patients with metastatic lymph nodes, more pTNM stage III, and less Borrmann type 1. The overall survival rate of patients with MGC was significantly lower than that of patients with SRC (P < 0.001).
MGC was an aggressive malignancy which had unique clinicopathological features.
黏液性胃癌(MGC)是一种罕见的恶性肿瘤,其预后尚不清楚。本研究旨在评估MGC的临床病理特征及预后。
我们回顾性分析了连续244例行D2淋巴结清扫根治性胃切除术的MGC患者,并将数据与260例胃印戒细胞癌(SRC)患者进行比较。
单因素生存分析显示,手术方式、原发肿瘤直径、Borrmann分型、肿瘤浸润深度(pT)、转移淋巴结病理数目(pN)、病理肿瘤淋巴结转移(pTNM)及血管侵犯均为生存的显著预测因素(均P < 0.05)。多因素生存分析显示,肿瘤直径、Borrmann分型、pT、pTNM分期及血管侵犯是生存的独立预测因素(均P < 0.05)。与SRC组相比,MGC组男性患者更多、老年患者更多、肿瘤直径更大、胃壁T3和T4浸润更多、有转移淋巴结的患者更多、pTNM III期患者更多,且Borrmann 1型更少。MGC患者的总生存率显著低于SRC患者(P < 0.001)。
MGC是一种侵袭性恶性肿瘤,具有独特的临床病理特征。